LabCompass

Camila Benaduce Emanuelli Mello

Medicine · Purdue University West Lafayette

Mid career · publishing since 2015

Publications

19

Citations

74

Est. group size

Recurring co-author estimate

Active years

12

Publishing since 2015

Research summary
AI-generated

This researcher works in veterinary clinical pathology and medicine, focusing on diagnosing diseases in companion animals (mainly dogs and cats) using cytology (examining cells under a microscope), histopathology (examining tissue samples), and laboratory tests. Their work covers topics such as tumor diagnosis, infectious diseases (bacterial, fungal), and toxicology studies of plant extracts, often through case reports and diagnostic accuracy studies published in Brazilian and international veterinary journals.

Veterinary clinical pathology and cytologyCancer diagnosis in companion animalsInfectious and bacterial disease case studies in animalsToxicology and safety testing of plant-derived compoundsDiagnostic laboratory methods for cavitary effusions and tumors

Publication output has fluctuated over the last decade, with a burst of activity in 2020 and 2022, a gap in 2023 and 2025, and an average of under two publications per year over the last five years.

Generated by claude-sonnet-5 from public bibliographic data · Jul 20, 2026

Publication cadence
Publications per year over the last 10 years — averaging 1.8/year recently
172018: 1 publication182019: 1 publication192020: 5 publications5202021: 2 publications212022: 4 publications22232024: 2 publications24252026: 3 publications26
Recent publications
Publishes in
  • Comparative Clinical Pathology×3
  • Veterinary Clinical Pathology×2
  • Regulatory Toxicology and Pharmacology×2
  • Ciência Rural×2
  • Zenodo (CERN European Organization for Nuclear Research)×2
Similar researchers
By research-topic overlap

This profile was generated automatically from public scholarly data (OpenAlex). Group size and activity levels are estimates derived from co-authorship patterns.

Last updated Jul 20, 2026.

Claim or correct this profile